Get directions
My saved places
MapQuest Travel
Route Planner
Print your map
Get help
Search the web
Send feedback
Learn more about our
mobile apps.
Enterprise solutions
Claim your business
Developer resources
Jobs
Advertise with us
Terms of use
Privacy policy
Data and licenses
About our ads
Do not sell
Advertisement
Advertisement
Search places or paste a link
Hotels
Food
Shopping
Coffee
Grocery
Gas
Hypnion
Save
Call
Share
Directions
Advertisement
Advertisement
141 Spring St
Cambridge, MA 02141
+1 (781) 778-0300
Also at this address
Square Biz General Contractors
Own this business?
Claim it
See a problem?
Let us know
You might also like
Biogen Idec
Bright Horizons at Biogen in Cambridge, MA is a childcare center that provides early education and care services for children of Biogen employees. With a focus on creating a nurturing and stimulating environment, the center offers a range of programs designed to support children's growth and development. Generated from their business information
Blood derivatives, Medical research, Biotechnical research, noncommercial
VBI Vaccines Inc
Since its establishment in 1970, the Paulson Investment Company has carved out a strong position as one of the leading investment bankers that specializes in small and emerging growth opportunities with capital needs from $5 million to $40 million. As one of the country s most active SmallCap investment bankers, Paulson works with some of the most successful entrepreneurs. The company is also one of the largest independent brokerage firms and is one of the leading investment bankers for emerging companies nationwide. Paulson offers a range of investment vehicles and insight into emerging business opportunities, online services and responsive support from broker to back office. The Paulson Investment Company maintains offices in Portland, Ore.
Real estate managers, Sizes, Services, nec, nec
Merrimack Pharmaceuticals
Cequent Pharmaceuticals, a privately held biopharmaceutical company based in Cambridge, Massachusetts, is at the forefront of developing novel therapeutics aimed at preventing and treating a variety of human diseases, including inflammatory diseases and cancer. Established in 2006, the company leverages its proprietary TransKingdom RNA interference (tkRNAi) technology to target specific disease-causing genes safely and effectively using non-pathogenic bacteria as delivery vehicles. The tkRNAi platform enables the development of drug candidates that can silence one or more cellular genes simultaneously, offering a powerful alternative to traditional small molecules and monoclonal antibodies. With its foundation rooted in groundbreaking scientific research from the Institut Pasteur in Paris and Beth Israel Deaconess Medical Center at Harvard Medical School, Cequent is poised to make significant advancements in the biopharmaceutical landscape. Generated from the website
United States
›
Massachusetts
›
Cambridge
›
Hypnion
Partial Data by Foursquare.
Advertisement
Advertisement